92 related articles for article (PubMed ID: 8651193)
1. Super turbo azathioprine: can Crohn's disease healing be accelerated?
Robinson M
Am J Gastroenterol; 1996 Jun; 91(6):1273-4. PubMed ID: 8651193
[No Abstract] [Full Text] [Related]
2. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year.
Vilien M; Dahlerup JF; Munck LK; Nørregaard P; Grønbaek K; Fallingborg J
Aliment Pharmacol Ther; 2004 Jun; 19(11):1147-52. PubMed ID: 15153167
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of intravenous azathioprine on time to respond for steroid treated Crohn's disease.
Carter MJ; Lobo AJ
Gut; 2001 Mar; 48(3):295-6. PubMed ID: 11171815
[No Abstract] [Full Text] [Related]
5. [Drug treatment of Crohn's disease].
van Deventer SJ; Tytgat GN
Ned Tijdschr Geneeskd; 1998 May; 142(21):1191-5. PubMed ID: 9627451
[TBL] [Abstract][Full Text] [Related]
6. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
[TBL] [Abstract][Full Text] [Related]
7. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
Egan LJ; Sandborn WJ; Tremaine WJ
Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of chronic inflammatory bowel diseases. TNF-alpha blocker in Crohn disease: earlier use is rewarding].
MMW Fortschr Med; 2008 Dec; 150(51-52):54-5. PubMed ID: 19156959
[No Abstract] [Full Text] [Related]
10. [Azathioprine treatment of Crohn disease].
Thomsen MK; Vilien M; Gerner CU
Ugeskr Laeger; 2000 Jan; 162(3):323-6. PubMed ID: 10680466
[TBL] [Abstract][Full Text] [Related]
11. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
Meier J; Sturm A
Z Gastroenterol; 2009 Feb; 47(2):240-2. PubMed ID: 19197829
[No Abstract] [Full Text] [Related]
12. [Response to stopping azathioprine in Crohn's patients on combined treatment with infliximab].
Martín De Carpi J; Varea V
An Pediatr (Barc); 2009 Mar; 70(3):271-7. PubMed ID: 19409244
[TBL] [Abstract][Full Text] [Related]
13. Azathioprine dose escalation in inflammatory bowel disease.
Rayner CK; Hart AL; Hayward CM; Emmanuel AV; Kamm MA
Aliment Pharmacol Ther; 2004 Jul; 20(1):65-71. PubMed ID: 15225172
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of Crohn disease recurrence with azathioprine--for whom, how long?].
Koop I; Schreiber S
Z Gastroenterol; 1997 Jan; 35(1):47-8. PubMed ID: 9123958
[No Abstract] [Full Text] [Related]
15. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of Crohn's disease with immunosuppressive agents].
Meuwissen SG
Ned Tijdschr Geneeskd; 1973 Feb; 117(8):311. PubMed ID: 4688232
[No Abstract] [Full Text] [Related]
17. [Azathioprine in Crohn's disease therapy--guidance against the background of recent studies].
Schmidt C; Herrlinger K; Siegmund B; Bokemeyer B; Schreiber S; Stallmach A;
Z Gastroenterol; 2014 Dec; 52(12):1423-30. PubMed ID: 25474282
[TBL] [Abstract][Full Text] [Related]
18. Commentary: Individual vs. weight-based dosing of azathioprine in Crohn's disease.
Fraser AG
Aliment Pharmacol Ther; 2014 Feb; 39(4):438-9. PubMed ID: 24447314
[No Abstract] [Full Text] [Related]
19. An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease.
Sandborn WJ; Van O EC; Zins BJ; Tremaine WJ; Mays DC; Lipsky JJ
Gastroenterology; 1995 Dec; 109(6):1808-17. PubMed ID: 7498645
[TBL] [Abstract][Full Text] [Related]
20. [Inflammatory bowel disease. If a patient with Crohn's disease remains in remission for 4 years with azathioprine (or mercaptopurine), should the drug be withdrawn?].
García López S
Gastroenterol Hepatol; 2008 Dec; 31(10):704-5. PubMed ID: 19280773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
